These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 22846185)

  • 21. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease.
    Ranganath SH; Levy O; Inamdar MS; Karp JM
    Cell Stem Cell; 2012 Mar; 10(3):244-58. PubMed ID: 22385653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transplantation of Human Placenta-Derived Mesenchymal Stem Cells Alleviates Critical Limb Ischemia in Diabetic Nude Rats.
    Liang L; Li Z; Ma T; Han Z; Du W; Geng J; Jia H; Zhao M; Wang J; Zhang B; Feng J; Zhao L; Rupin A; Wang Y; Han ZC
    Cell Transplant; 2017 Jan; 26(1):45-61. PubMed ID: 27501782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesenchymoangioblast-derived mesenchymal stromal cells inhibit cell damage, tissue damage and improve peripheral blood flow following hindlimb ischemic injury in mice.
    Koch JM; D'Souza SS; Schwahn DJ; Dixon I; Hacker TA
    Cytotherapy; 2016 Feb; 18(2):219-28. PubMed ID: 26740280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inducible metabolic adaptation promotes mesenchymal stem cell therapy for ischemia: a hypoxia-induced and glycogen-based energy prestorage strategy.
    Zhu H; Sun A; Zou Y; Ge J
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):870-6. PubMed ID: 24558105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal stem cells for inflammatory airway disorders: promises and challenges.
    Fan XL; Zhang Z; Ma CY; Fu QL
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30610158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and Safety of Autologous Cell-based Therapy in Patients with No-option Critical Limb Ischaemia: A Meta-Analysis.
    Wahid FSA; Ismail NA; Wan Jamaludin WF; Muhamad NA; Mohamad Idris MA; Lai NM
    Curr Stem Cell Res Ther; 2018; 13(4):265-283. PubMed ID: 29532760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke.
    Eckert MA; Vu Q; Xie K; Yu J; Liao W; Cramer SC; Zhao W
    J Cereb Blood Flow Metab; 2013 Sep; 33(9):1322-34. PubMed ID: 23756689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemia.
    HoWangYin KY; Loinard C; Bakker W; Guérin CL; Vilar J; d'Audigier C; Mauge L; Bruneval P; Emmerich J; Lévy BI; Pouysségur J; Smadja DM; Silvestre JS
    Stem Cells; 2014 Jan; 32(1):231-43. PubMed ID: 24105925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transplantation of erythropoietin gene-transfected umbilical cord mesenchymal stem cells as a treatment for limb ischemia in rats.
    Li JP; Wang DW; Song QH
    Genet Mol Res; 2015 Dec; 14(4):19005-15. PubMed ID: 26782551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesenchymal stromal/stem cells as potential therapy in diabetic retinopathy.
    Fiori A; Terlizzi V; Kremer H; Gebauer J; Hammes HP; Harmsen MC; Bieback K
    Immunobiology; 2018 Dec; 223(12):729-743. PubMed ID: 29402461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human adipose tissue-derived mesenchymal stem cells improve postnatal neovascularization in a mouse model of hindlimb ischemia.
    Moon MH; Kim SY; Kim YJ; Kim SJ; Lee JB; Bae YC; Sung SM; Jung JS
    Cell Physiol Biochem; 2006; 17(5-6):279-90. PubMed ID: 16791003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. shRNA-mediated decreases in c-Met levels affect the differentiation potential of human mesenchymal stem cells and reduce their capacity for tissue repair.
    Rosová I; Link D; Nolta JA
    Tissue Eng Part A; 2010 Aug; 16(8):2627-39. PubMed ID: 20367286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primed 3D injectable microniches enabling low-dosage cell therapy for critical limb ischemia.
    Li Y; Liu W; Liu F; Zeng Y; Zuo S; Feng S; Qi C; Wang B; Yan X; Khademhosseini A; Bai J; Du Y
    Proc Natl Acad Sci U S A; 2014 Sep; 111(37):13511-6. PubMed ID: 25197069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simvastatin augments the efficacy of therapeutic angiogenesis induced by bone marrow-derived mesenchymal stem cells in a murine model of hindlimb ischemia.
    Zhang Y; Zhang R; Li Y; He G; Zhang D; Zhang F
    Mol Biol Rep; 2012 Jan; 39(1):285-93. PubMed ID: 21553056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-Met-Activated Mesenchymal Stem Cells Rescue Ischemic Damage via Interaction with Cellular Prion Protein.
    Han YS; Yun SP; Lee JH; Kwon SH; Kim S; Hur J; Lee SH
    Cell Physiol Biochem; 2018; 46(5):1835-1848. PubMed ID: 29705776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aldehyde dehydrogenase-2 is a host factor required for effective bone marrow mesenchymal stem cell therapy.
    Zhu H; Sun A; Zhu H; Li Z; Huang Z; Zhang S; Ma X; Zou Y; Hu K; Ge J
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):894-901. PubMed ID: 24558108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transplantation of Cardiac Mesenchymal Stem Cell-Derived Exosomes for Angiogenesis.
    Ju C; Li Y; Shen Y; Liu Y; Cai J; Liu N; Ma G; Tang Y
    J Cardiovasc Transl Res; 2018 Oct; 11(5):429-437. PubMed ID: 30276617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic Properties of Mesenchymal Stromal/Stem Cells: The Need of Cell Priming for Cell-Free Therapies in Regenerative Medicine.
    Miceli V; Bulati M; Iannolo G; Zito G; Gallo A; Conaldi PG
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal changes guided by mesenchymal stem cells on a 3D microgel platform enhance angiogenesis in vivo at a low-cell dose.
    Thomas D; Marsico G; Mohd Isa IL; Thirumaran A; Chen X; Lukasz B; Fontana G; Rodriguez B; Marchetti-Deschmann M; O'Brien T; Pandit A
    Proc Natl Acad Sci U S A; 2020 Aug; 117(32):19033-19044. PubMed ID: 32709748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancing Retention of Human Bone Marrow Mesenchymal Stem Cells with Prosurvival Factors Promotes Angiogenesis in a Mouse Model of Limb Ischemia.
    Cortez-Toledo E; Rose M; Agu E; Dahlenburg H; Yao W; Nolta JA; Zhou P
    Stem Cells Dev; 2019 Jan; 28(2):114-119. PubMed ID: 30398391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.